Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.38 USD | -11.48% |
|
-10.53% | +55.74% |
Jun. 04 | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.